These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 21838682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
    Boesch M, Zeimet AG, Rumpold H, Gastl G, Sopper S, Wolf D.
    Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
    [Abstract] [Full Text] [Related]

  • 3. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J, Zhang X, Wang F, Wang X, Yang K, Xu M, To KK, Li Q, Fu L.
    Oncotarget; 2015 Dec 29; 6(42):44643-59. PubMed ID: 26556876
    [Abstract] [Full Text] [Related]

  • 4. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M, Mäbert K, Muders MH, Dubrovska A.
    Semin Cancer Biol; 2015 Apr 29; 31():16-27. PubMed ID: 24956577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
    Yu M, Ocana A, Tannock IF.
    Cancer Metastasis Rev; 2013 Jun 29; 32(1-2):211-27. PubMed ID: 23093326
    [Abstract] [Full Text] [Related]

  • 7. ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy.
    Cui H, Zhang AJ, Chen M, Liu JJ.
    Curr Drug Targets; 2015 Jun 29; 16(12):1356-71. PubMed ID: 25901528
    [Abstract] [Full Text] [Related]

  • 8. lncRNAs: New players of cancer drug resistance via targeting ABC transporters.
    Ebrahimnezhad M, Asl SH, Rezaie M, Molavand M, Yousefi B, Majidinia M.
    IUBMB Life; 2024 Nov 29; 76(11):883-921. PubMed ID: 39091106
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relevance of multidrug resistance in the age of targeted therapy.
    Türk D, Szakács G.
    Curr Opin Drug Discov Devel; 2009 Mar 29; 12(2):246-52. PubMed ID: 19333870
    [Abstract] [Full Text] [Related]

  • 13. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A, Livney YD, Broxterman HJ, Assaraf YG.
    Drug Resist Updat; 2011 Jun 29; 14(3):150-63. PubMed ID: 21330184
    [Abstract] [Full Text] [Related]

  • 14. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN, Sheu MJ, Hsieh YW, Wang RY, Chiang YC, Hung CC.
    Phytomedicine; 2016 Mar 15; 23(3):316-23. PubMed ID: 26969385
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R.
    Curr Med Chem; 2006 Mar 15; 13(16):1859-76. PubMed ID: 16842198
    [Abstract] [Full Text] [Related]

  • 17. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
    Begicevic RR, Falasca M.
    Int J Mol Sci; 2017 Nov 08; 18(11):. PubMed ID: 29117122
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG.
    Drug Resist Updat; 2006 Nov 08; 9(4-5):227-46. PubMed ID: 17092765
    [Abstract] [Full Text] [Related]

  • 20. The ABCs of cancer stem cell drug resistance.
    Elliott A, Adams J, Al-Hajj M.
    IDrugs; 2010 Sep 08; 13(9):632-5. PubMed ID: 20799146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.